美国健康科技公司 Tempus AI (NASDAQ:TEM) 公布第四季度业绩,盘后交易中股价下跌11%。
Tempus AI Inc.四季度净收入2.007亿美元,其中Genomics营收1.204亿美元、数据与服务营收0.802亿美元。四季度净亏损0.13亿美元。
Tempus创始人兼首席执行官Eric Lefkofsky表示:"我们2024年的业绩表现反映了核心业务的实力,基因组业务继续保持强劲的业务量增长,数据业务全年创下记录性业绩。"
对于2025全年,Tempus预计营收约为12.4亿美元,年增长率为79%。公司还预计在2025年实现500万美元的调整后EBITDA,较2024年改善约1.1亿美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.